Market Wrap Up: Chevron Corporation (NYSE:CVX), Semtech Corporation (NASDAQ:SMTC), Craft Brew Alliance, Inc. (NASDAQ:BREW), La Jolla Pharmaceutical Co. (NASDAQ:LJPC), JPMorgan Chase (NYSE:JPM)

New Zealand awarded 15 oil and gas exploration licenses on Tuesday, with U.S. giant Chevron Corporation (NYSE:CVX) and India’s ONGC Videsh joining the hunt in the South Pacific country for the first time. Chevron is partnering with Norway’s Statoil to explore three prospects off the lightly explored south-east coast of the North Island. Chevron Corporation (NYSE:CVX) belongs to Basic Materials sector. Its net profit margin … Continue reading Market Wrap Up: Chevron Corporation (NYSE:CVX), Semtech Corporation (NASDAQ:SMTC), Craft Brew Alliance, Inc. (NASDAQ:BREW), La Jolla Pharmaceutical Co. (NASDAQ:LJPC), JPMorgan Chase (NYSE:JPM)

Jayne Crisman12/1012/10

Stock Highlights: Gerdau (NYSE:GGB), La Jolla Pharmaceutical Co. (NASDAQ:LJPC), TriNet Group, Inc. (NYSE:TNET), Harley-Davidson, Inc. (NYSE:HOG), Credit Acceptance Corp. (NASDAQ:CACC)

Gerdau SA (NYSE:GGB) has earned credit rating from Morningstar. The credit rating agency’s “BBB-” rating suggests that the company is a moderate default risk. They also issued a negative credit outlook for the company and gave their stock a three star rating. Gerdau S.A. (NYSE:GGB) belongs to Basic Materials sector. Its net profit margin is 4.20% and weekly performance is -11.07%. On last trading day … Continue reading Stock Highlights: Gerdau (NYSE:GGB), La Jolla Pharmaceutical Co. (NASDAQ:LJPC), TriNet Group, Inc. (NYSE:TNET), Harley-Davidson, Inc. (NYSE:HOG), Credit Acceptance Corp. (NASDAQ:CACC)

John Meady09/1209/12

Worth Watching Stocks : La Jolla Pharmaceutical (NASDAQ:LJPC), Corcept (NASDAQ:CORT), Grupo Aeroportuario (NASDAQ:OMAB), Facebook (NASDAQ:FB), Elephant Talk Communications (NYSEMKT:ETAK)

La Jolla Pharmaceutical Company (NASDAQ:LJPC) (the “Company” or “La Jolla”) a leader in the development of therapeutics targeting significant unmet life-threatening diseases today announced that George Tidmarsh M.D. Ph.D. President and Chief Executive Officer will provide a corporate overview at the 2014 Wedbush Securities Life Sciences Conference taking place August 12-13 in New York City. La Jolla Pharmaceutical Co. (NASDAQ:LJPC) belongs to Healthcare sector. Its … Continue reading Worth Watching Stocks : La Jolla Pharmaceutical (NASDAQ:LJPC), Corcept (NASDAQ:CORT), Grupo Aeroportuario (NASDAQ:OMAB), Facebook (NASDAQ:FB), Elephant Talk Communications (NYSEMKT:ETAK)

Jayne Crisman08/1208/12

FB Nasdaq FB Facebook

Biotech Losers: Agenus Inc (NASDAQ:AGEN), La Jolla Pharmaceutical Company (NASDAQ:LJPC), Durata Therapeutics (NASDAQ:DRTX), Galmed Pharmaceuticals (NASDAQ:GLMD)

Shares of Agenus Inc (NASDAQ:AGEN) , a biopharmaceutical company focused on developing novel immunotherapies to treat cancer and a number of other unmet diseases, tumbled by as much as 22% after partner GlaxoSmithKline (NYSE: GSK ) announced that its phase 3 MAGE-A3 cancer immunotherapeutic trial in non-small cell lung cancer (NSCLC) patients didn’t meet its first or second coprimary endpoint. Agenus Inc (NASDAQ:AGEN) stock performance … Continue reading Biotech Losers: Agenus Inc (NASDAQ:AGEN), La Jolla Pharmaceutical Company (NASDAQ:LJPC), Durata Therapeutics (NASDAQ:DRTX), Galmed Pharmaceuticals (NASDAQ:GLMD)

Kevin Long03/2103/21

Biotech Unusual Volume Stocks: Arca Biopharma (NASDAQ:ABIO), Biota Pharmaceuticals (NASDAQ:BOTA), Lpath (NASDAQ:LPTN), La Jolla Pharmaceutical (NASDAQ:LJPC)

Arca Biopharma Inc (NASDAQ:ABIO) focuses on developing genetically targeted therapies for cardiovascular disease. Its lead product candidate, Gencaro, is an investigational, pharmacologically unique beta-blocker and mild vasodilator being developed for the prevention of atrial fibrillation in patients with heart failure and reduced left ventricular ejection fraction. Arca Biopharma Inc (NASDAQ:ABIO) stock performance was 11.34% in last session and finished the day at $2.16. Traded volume … Continue reading Biotech Unusual Volume Stocks: Arca Biopharma (NASDAQ:ABIO), Biota Pharmaceuticals (NASDAQ:BOTA), Lpath (NASDAQ:LPTN), La Jolla Pharmaceutical (NASDAQ:LJPC)

Mark DeFrance03/1303/13

Biotech Unusual Volume: Northwest Biotherapeutics (NASDAQ:NWBO), La Jolla Pharmaceutical Company (NASDAQ:LJPC), OXiGENE (NASDAQ:OXGN), Tengion (OTCMKTS:TNGN)

Northwest Biotherapeutics Inc (NASDAQ:NWBO) a biotechnology company developing DCVax personalized immune therapies for solid tumour cancers, has received approval from the Paul Ehrlich Institute (PEI- the FDA of Germany) of a “Hospital Exemption” early access programme under Section 4b of the German Drug Law. Northwest Biotherapeutics, Inc (NASDAQ:NWBO) stock performance was 16.93% in last session and finished the day at $9.18. Traded volume was 8,391,894 … Continue reading Biotech Unusual Volume: Northwest Biotherapeutics (NASDAQ:NWBO), La Jolla Pharmaceutical Company (NASDAQ:LJPC), OXiGENE (NASDAQ:OXGN), Tengion (OTCMKTS:TNGN)

Mark DeFrance03/1203/12